All answers
apps6 minBiohacking AI EditorialLast reviewed

Can AI explain supplement studies in plain language?

Specialized AI like Biohacking AI translates peer-reviewed supplement studies into understandable answers with clickable sources. Generic AI risks hallucinated study IDs.

Direct answer

Yes — a specialized AI translates supplement studies very well by extracting methodology (RCT vs. observation vs. animal), sample size, duration, and concrete effect sizes from primary-study originals and bringing them into understandable form. Important: this only works with tools that have real live access to the research literature (e.g. Biohacking AI). Generic AI chats (ChatGPT, Claude, Gemini) regularly hallucinate non-existent PMIDs on specific study queries.

What a good study explanation does

It translates methodology

Instead of just saying "a study shows X", a good AI ranks the methodology: meta-analysis (strongest — synthesizes many studies), RCT (gold standard of single studies), cohort study (shows association, not causation), case series (descriptive), animal study (biologically plausible, not human).

Example: "Studies on ashwagandha are primarily RCTs with small samples (n=30-80), short duration (4-8 weeks), mixed conflict-of-interest. A systematic meta-analysis is currently missing."

It names concrete effect sizes

Instead of "significantly improves sleep" → "improves sleep quality (PSQI score) by -1.5 points in n=58 older adults with insomnia, effect size moderate (d=0.4)". Concrete numbers, no marketing-speak.

It shows gaps explicitly

"Data on lion's mane in young adults with normal cognition are thin — most studies focus on mild cognitive impairment in the elderly." Instead of inventing where nothing exists.

It links to the primary source

Clickable links to scientific sources for every cited study so you can read it yourself. "Trust but verify" — only works with cited sources.

Where generic AI fails

Hallucination risk: You ask ChatGPT: "Which study shows NMN's effect on NAD+ levels in humans?" → ChatGPT answers with "Smith et al. 2022, PMID 35XXXXXX shows 38% NAD+ increase" — and you find neither Smith 2022 nor the PMID in the research literature. Invented. On health topics: recurring documented problem.

Outdated training knowledge: training data has cutoffs (often 1-2 years old). Newer studies are missing. On rapidly evolving topics (e.g. GLP-1, peptides), live databases are needed.

No methodology ranking: generic AI often treats a small pilot study like a large meta-analysis. Differentiation of evidence levels is often missing.

How Biohacking AI does this

Example query: "How well is magnesium bisglycinate supported for sleep problems?"

  1. Live study search for "magnesium bisglycinate sleep" and related terms
  2. Aggregation: Abbasi 2012 (PMID 23853635) identified as strongest study
  3. Translation: "RCT, n=46, older adults with primary insomnia, 500 mg magnesium/day, 8 weeks. PSQI improvement -1.5 points, sleep latency -17 min, moderate effect."
  4. Evidence level: B+ (RCT, moderate sample, replication needed)
  5. Caveat: "Participants were older and with documented insomnia. Transferability to younger adults without sleep disorder unclear."
  6. Clickable link to the study in the research literature.

All in 5-10 seconds, no hallucination.

Methodology — what we check in translation

Four points per study: a) Study type (RCT > observation > animal), b) sample size + duration, c) effect size in numbers (not just p-value), d) conflict of interest. A study is clearly classified as "strong signal", "preliminary indication", or "not convincing" — not as generic "studies show…".

Sources

Related answers

Frequently asked questions

What separates a supplement study from a marketing claim?
A study has: methodology (RCT, observation, animal), sample size, duration, defined endpoint, p-value AND effect size, conflict-of-interest statement. Marketing claims often only say 'clinically tested' without details. AI with research-literature access can show the difference precisely.
How does Biohacking AI translate a study?
Example: 'Creatine improves strength' → Biohacking AI opens Kreider 2017 (PMID 28615996), shows: RCT meta-analysis, >1000 studies, effect size ~+8% max strength, safe at doses 3-5 g/day. Plus: 'Caution: creatinine values rise falsely (no real kidney problem).' Source clickable for validation.
Can ChatGPT reliably explain supplement studies?
For broadly established studies (creatine, vitamin D) often accurate — because the knowledge is multiply represented in the training corpus. For specific PMID queries, ChatGPT regularly hallucinates. Risk: you can't check what really exists. Specialized tools with live research-literature access avoid that.
What does 'effect size' mean and why is it more important than p-value?
P-value says: 'probably not random'. Effect size says: 'how big the effect is'. Example: 'significantly lowers LDL' (p < 0.05) can mean -2 mg/dl — statistically significant, clinically irrelevant. Effect size in numbers (Cohen's d 0.2 small, 0.5 medium, 0.8 large) is the real evaluation.
Does AI detect conflict-of-interest in studies?
Better tools (with full-text access) yes. Study abstracts often don't contain the COI statement; only full text shows it. Biohacking AI flags industry-funded studies explicitly when the information is available. Generic AI usually sees only the abstract and can't reliably name COI.
Can AI tell me whether a study has been replicated?
Better tools can find cross-citations and follow-up replication studies ('Has study X been confirmed by Y?'). Generic chats have no systematic replication view. At Biohacking AI this is part of the evidence-level rating — a singly published, non-replicated study gets a lower level than one replicated 5×.
About the author
Biohacking AI Editorial

Evidence-focused. We translate methodology, not just buzzwords.